JRC Publications Repository

JRC Publications Repository >

Browsing by Author MCDEVITT Michael

Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 2 of 2
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2013Alpha-Particle Immunotherapy for Acute Myeloid Leukemia (AML) with Bismuth-213 (213Bi) and Actinium-225 (225Ac)JURCIC J. G.; ROSENBLAT Todd; MCDEVITT Michael; PANDIT-TASKAR N.; CARRASQUILLO Jorge; SGOUROS G.; MORGENSTERN Alfred; CICIC Dragan; LARSON S. M.; SCHEINBERG D. A.Contributions to Conferences
2010Sequential Cytarabine and a-Particle Immunotherapy with Bismuth-213¿Lintuzumab (HuM195) for Acute Myeloid LeukemiaROSENBLAT Todd; MCDEVITT Michael; MULFORD D.a.; PANDIT-TASKAR N.; DIVGI C.r.; PANAGEAS Katherine; HEANEY M. L.; CHANEL S.; MORGENSTERN Alfred; SGOUROS George; LARSON S. M.; SCHEINBERG D. A.; JURCIC J. G.Articles in Journals
Showing results 1 to 2 of 2

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top